The Slovakian market for Penicillins and Streptomycins saw fluctuations from 2013 to 2023, reaching a value of $15.231 million in 2023. The period from 2013 recorded minor gains until 2014, followed by a steep decline in 2015 and 2016. A series of decreases persisted through 2019, with a brief recovery in 2020 and 2021. However, significant drops occurred again in 2022 and 2023. Over the last two years, the market contracted by 16.1%. A consistent 3.84% decline was seen annually over the past five years.

Future trends to watch:

Potential shifts in healthcare policies and budget allocations in Slovakia.
Emerging technological advancements in antibiotic production.
Public health awareness and antibiotic usage regulations that could influence market demand.